What was corrected and how
A subsequent correction by the company to the contents of an already published filing.
Summary of Financial Results for the Fiscal Year Ended June 2024 [Japanese GAAP] (Consolidated)
<Attached Materials, pages 15 and 16> 3. Consolidated Financial Statements and Principal Notes, (5) Notes to Consolidated Financial Statements (Segment Information, etc.), 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reporting segment
Previous consolidated fiscal year Adjustments 407,207 / Amount reported in the consolidated financial statements 1,391,790 / The current consolidated fiscal year Medical Device Sales Business 1,294,148 / Total Reportable Segments 1,738,144 / Adjustments 735,612 / Amount reported in the consolidated financial statements 2,473,757
Previous consolidated fiscal year Adjustments 418,485 / Amount reported in the consolidated financial statements 1,403,068 / The current consolidated fiscal year Medical Device Sales Business 1,292,869 / Total Reportable Segments 1,736,865 / Adjustments 1,676,056 / Amount reported in the consolidated financial statements 3,412,921
This correction is being made because it was discovered that some aggregation errors had been made in the amounts of increases in property, plant and equipment and intangible assets in the “Segment Information, etc.” section of the “Summary of Financial Results for the Fiscal Year Ended June 2024 [Japanese GAAP] (Consolidated).”
| Item | Details |
|---|---|
| Disclosure subject to correction | Summary of Financial Results for the Fiscal Year Ended June 2024 [Japanese GAAP] (Consolidated) |
| Original disclosure date | 8 August 2024 |
| Location of correction | <Attached Materials, pages 15 and 16> 3. Consolidated Financial Statements and Principal Notes, (5) Notes to Consolidated Financial Statements (Segment Information, etc.), 3. Information on the amounts of net sales, profit or loss, assets, liabilities and other items by reporting segment |
| Details of correction | Previous consolidated fiscal year Adjustments 407,207 / Amount reported in the consolidated financial statements 1,391,790 / The current consolidated fiscal year Medical Device Sales Business 1,294,148 / Total Reportable Segments 1,738,144 / Adjustments 735,612 / Amount reported in the consolidated financial statements 2,473,757 → Previous consolidated fiscal year Adjustments 418,485 / Amount reported in the consolidated financial statements 1,403,068 / The current consolidated fiscal year Medical Device Sales Business 1,292,869 / Total Reportable Segments 1,736,865 / Adjustments 1,676,056 / Amount reported in the consolidated financial statements 3,412,921 |
| Reason for correction | This correction is being made because it was discovered that some aggregation errors had been made in the amounts of increases in property, plant and equipment and intangible assets in the “Segment Information, etc.” section of the “Summary of Financial Results for the Fiscal Year Ended June 2024 [Japanese GAAP] (Consolidated).” |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because it was discovered that some aggregation errors had been made in the amounts of increases in property, plant and equipment and intangible assets.